News
Key Takeaways The Decipher Prostate genomic classifier — a genomic test performed on biopsy samples to gauge the expression of 22 genes involved in prostate cancer progression — was associated ...
SAN FRANCISCO — Decipher, a genomic test for prostate cancer (PCa), may predict poor disease-specific outcomes more accurately in African-American men (AAM) than in European-American men (EAM ...
The Decipher genomic classifier predicted metastases and prostate cancer-specific mortality following radical prostatectomy with greater precision in African-American men.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback